Cargando…

Seroprevalence of SARS-CoV-2 and Risk Assessment Among Healthcare Workers at a Dedicated Tertiary Care COVID-19 Hospital in Delhi, India: A Cohort Study

Background Healthcare workers (HCWs) have a substantially higher risk of Covid-19 infection but there is a paucity of information on the risk factors of disease transmission in high-burden real-world settings. The study objective was to determine the seroprevalence of SARS-CoV-2 among healthcare wor...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Pragya, Chawla, Rohit, Basu, Saurav, Saxena, Sonal, Mariam, Warisha, Bharti, Pradeep Kumar, Rao, Shivani, Tanwar, Neha, Rahman, Anisur, Ahmad, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810309/
https://www.ncbi.nlm.nih.gov/pubmed/35145765
http://dx.doi.org/10.7759/cureus.20805
_version_ 1784644226482438144
author Sharma, Pragya
Chawla, Rohit
Basu, Saurav
Saxena, Sonal
Mariam, Warisha
Bharti, Pradeep Kumar
Rao, Shivani
Tanwar, Neha
Rahman, Anisur
Ahmad, Mohammad
author_facet Sharma, Pragya
Chawla, Rohit
Basu, Saurav
Saxena, Sonal
Mariam, Warisha
Bharti, Pradeep Kumar
Rao, Shivani
Tanwar, Neha
Rahman, Anisur
Ahmad, Mohammad
author_sort Sharma, Pragya
collection PubMed
description Background Healthcare workers (HCWs) have a substantially higher risk of Covid-19 infection but there is a paucity of information on the risk factors of disease transmission in high-burden real-world settings. The study objective was to determine the seroprevalence of SARS-CoV-2 among healthcare workers in a high-burden Covid-19 setting and to estimate the incidence and identify the risk factors of infection. Methods This was a prospective observational cohort study amongst doctors and nurses working at a dedicated Covid-19 tertiary care government hospital in Delhi, India. A baseline blood sample (2-3ml) was collected from all the participants to test for the presence of total SARS-CoV-2 antibodies. The HCWs that were seronegative (non-reactive) at baseline were followed-up for ≥21≤28 days with the collection of a second blood sample to assess for the incidence of SARS-CoV-2 infection. Results A total of 321 (51.3%, 95% C.I 47.4, 55.3) HCWs were detected with SARS-CoV-2 antibodies on baseline examination. The seroprevalence, when adjusted for assay characteristics, was 54.5% (95% C.I 50.3, 58.6). On bivariate analysis, SARS-CoV-2 antibody positivity lacked statistically significant association with either age, sex, occupation, cumulative duty duration, and smoking status. The incidence of seroconversion in the baseline seronegative cohort on follow-up after 21-28 days was observed in 35 (14.9%) HCWs (n=245). Furthermore, the self-reported adherence to infection prevention and control measures did not show a statistically significant association with antibody positivity in the HCWs, neither at baseline nor on follow-up. Conclusions  The high risk of SARS-CoV-2 transmission in HCWs may be substantially reduced by adherence to Infection Prevention Control (IPC) and protective measures. 
format Online
Article
Text
id pubmed-8810309
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-88103092022-02-09 Seroprevalence of SARS-CoV-2 and Risk Assessment Among Healthcare Workers at a Dedicated Tertiary Care COVID-19 Hospital in Delhi, India: A Cohort Study Sharma, Pragya Chawla, Rohit Basu, Saurav Saxena, Sonal Mariam, Warisha Bharti, Pradeep Kumar Rao, Shivani Tanwar, Neha Rahman, Anisur Ahmad, Mohammad Cureus Preventive Medicine Background Healthcare workers (HCWs) have a substantially higher risk of Covid-19 infection but there is a paucity of information on the risk factors of disease transmission in high-burden real-world settings. The study objective was to determine the seroprevalence of SARS-CoV-2 among healthcare workers in a high-burden Covid-19 setting and to estimate the incidence and identify the risk factors of infection. Methods This was a prospective observational cohort study amongst doctors and nurses working at a dedicated Covid-19 tertiary care government hospital in Delhi, India. A baseline blood sample (2-3ml) was collected from all the participants to test for the presence of total SARS-CoV-2 antibodies. The HCWs that were seronegative (non-reactive) at baseline were followed-up for ≥21≤28 days with the collection of a second blood sample to assess for the incidence of SARS-CoV-2 infection. Results A total of 321 (51.3%, 95% C.I 47.4, 55.3) HCWs were detected with SARS-CoV-2 antibodies on baseline examination. The seroprevalence, when adjusted for assay characteristics, was 54.5% (95% C.I 50.3, 58.6). On bivariate analysis, SARS-CoV-2 antibody positivity lacked statistically significant association with either age, sex, occupation, cumulative duty duration, and smoking status. The incidence of seroconversion in the baseline seronegative cohort on follow-up after 21-28 days was observed in 35 (14.9%) HCWs (n=245). Furthermore, the self-reported adherence to infection prevention and control measures did not show a statistically significant association with antibody positivity in the HCWs, neither at baseline nor on follow-up. Conclusions  The high risk of SARS-CoV-2 transmission in HCWs may be substantially reduced by adherence to Infection Prevention Control (IPC) and protective measures.  Cureus 2021-12-29 /pmc/articles/PMC8810309/ /pubmed/35145765 http://dx.doi.org/10.7759/cureus.20805 Text en Copyright © 2021, Sharma et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Preventive Medicine
Sharma, Pragya
Chawla, Rohit
Basu, Saurav
Saxena, Sonal
Mariam, Warisha
Bharti, Pradeep Kumar
Rao, Shivani
Tanwar, Neha
Rahman, Anisur
Ahmad, Mohammad
Seroprevalence of SARS-CoV-2 and Risk Assessment Among Healthcare Workers at a Dedicated Tertiary Care COVID-19 Hospital in Delhi, India: A Cohort Study
title Seroprevalence of SARS-CoV-2 and Risk Assessment Among Healthcare Workers at a Dedicated Tertiary Care COVID-19 Hospital in Delhi, India: A Cohort Study
title_full Seroprevalence of SARS-CoV-2 and Risk Assessment Among Healthcare Workers at a Dedicated Tertiary Care COVID-19 Hospital in Delhi, India: A Cohort Study
title_fullStr Seroprevalence of SARS-CoV-2 and Risk Assessment Among Healthcare Workers at a Dedicated Tertiary Care COVID-19 Hospital in Delhi, India: A Cohort Study
title_full_unstemmed Seroprevalence of SARS-CoV-2 and Risk Assessment Among Healthcare Workers at a Dedicated Tertiary Care COVID-19 Hospital in Delhi, India: A Cohort Study
title_short Seroprevalence of SARS-CoV-2 and Risk Assessment Among Healthcare Workers at a Dedicated Tertiary Care COVID-19 Hospital in Delhi, India: A Cohort Study
title_sort seroprevalence of sars-cov-2 and risk assessment among healthcare workers at a dedicated tertiary care covid-19 hospital in delhi, india: a cohort study
topic Preventive Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810309/
https://www.ncbi.nlm.nih.gov/pubmed/35145765
http://dx.doi.org/10.7759/cureus.20805
work_keys_str_mv AT sharmapragya seroprevalenceofsarscov2andriskassessmentamonghealthcareworkersatadedicatedtertiarycarecovid19hospitalindelhiindiaacohortstudy
AT chawlarohit seroprevalenceofsarscov2andriskassessmentamonghealthcareworkersatadedicatedtertiarycarecovid19hospitalindelhiindiaacohortstudy
AT basusaurav seroprevalenceofsarscov2andriskassessmentamonghealthcareworkersatadedicatedtertiarycarecovid19hospitalindelhiindiaacohortstudy
AT saxenasonal seroprevalenceofsarscov2andriskassessmentamonghealthcareworkersatadedicatedtertiarycarecovid19hospitalindelhiindiaacohortstudy
AT mariamwarisha seroprevalenceofsarscov2andriskassessmentamonghealthcareworkersatadedicatedtertiarycarecovid19hospitalindelhiindiaacohortstudy
AT bhartipradeepkumar seroprevalenceofsarscov2andriskassessmentamonghealthcareworkersatadedicatedtertiarycarecovid19hospitalindelhiindiaacohortstudy
AT raoshivani seroprevalenceofsarscov2andriskassessmentamonghealthcareworkersatadedicatedtertiarycarecovid19hospitalindelhiindiaacohortstudy
AT tanwarneha seroprevalenceofsarscov2andriskassessmentamonghealthcareworkersatadedicatedtertiarycarecovid19hospitalindelhiindiaacohortstudy
AT rahmananisur seroprevalenceofsarscov2andriskassessmentamonghealthcareworkersatadedicatedtertiarycarecovid19hospitalindelhiindiaacohortstudy
AT ahmadmohammad seroprevalenceofsarscov2andriskassessmentamonghealthcareworkersatadedicatedtertiarycarecovid19hospitalindelhiindiaacohortstudy